The first evaluable patient in Cohort 2 (Patient 6) demonstrated a clear dose response, and early MyBP-C expression increased by 14% after only 12 weeks post-dose. Of note, Patient 6 had a greater ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback